Cranbrook Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Cranbrook Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$686K	Sell	1,368 -90	-6%	-$43.2K	0.13%	78
2026 Q1	$717K	Hold	1,458	–	–	0.15%	72
2025 Q4	$845K	Buy	1,458 +414	+40%	+$234K	0.17%	66
2025 Q3	$506K	Hold	1,044	–	–	0.1%	79
2025 Q2	$423K	Hold	1,044	–	–	0.09%	86
2025 Q1	$519K	Sell	1,044 -29	-3%	-$15.7K	0.12%	76
2024 Q4	$558K	Hold	1,073	–	–	0.13%	74
2024 Q3	$664K	Hold	1,073	–	–	0.15%	69
2024 Q2	$593K	Buy	1,073 +1,007	+1,526%	+$577K	0.15%	67
2024 Q1	$38.4K	Hold	66	–	–	0.01%	174
2023 Q4	$35K	Hold	66	–	–	0.01%	174
2023 Q3	$33.4K	Hold	66	–	–	0.01%	170
2023 Q2	$34.4K	Hold	66	–	–	0.01%	174
2023 Q1	$38K	Hold	66	–	–	0.01%	167
2022 Q4	$36.3K	Hold	66	–	–	0.01%	173
2022 Q3	$33K	Hold	66	–	–	0.01%	192
2022 Q2	$36K	Hold	66	–	–	0.01%	188
2022 Q1	$39K	Hold	66	–	–	0.01%	202
2021 Q4	$44K	Hold	66	–	–	0.01%	193
2021 Q3	$38K	Buy	66 +20	+43%	+$11K	0.01%	212
2021 Q2	$23K	Sell	46 -27	-37%	-$12.7K	0.01%	233
2021 Q1	$33K	Buy	73 +27	+59%	+$12.9K	0.01%	215
2020 Q4	$21K	Hold	46	–	–	0.01%	204
2020 Q3	$20K	Hold	46	–	–	0.01%	182
2020 Q2	$17K	Hold	46	–	–	0.01%	186
2020 Q1	$13K	Hold	46	–	–	﹤0.01%	188
2019 Q4	$15K	Hold	46	–	–	﹤0.01%	191
2019 Q3	$13K	Hold	46	–	–	﹤0.01%	191
2019 Q2	$14K	Hold	46	–	–	﹤0.01%	185
2019 Q1	$13K	Hold	46	–	–	﹤0.01%	187
2018 Q4	$10K	Hold	46	–	–	﹤0.01%	186
2018 Q3	$11K	Hold	46	–	–	﹤0.01%	181
2018 Q2	$10K	Buy	+46	New	+$9.76K	﹤0.01%	179

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Cranbrook Wealth Management's TMO Position: Q2 2026 in Review

Cranbrook Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 6.2% in Q2 2026, selling an estimated $43.2K and leaving 1,368 shares worth $686K. The position accounts for 0.13% of the portfolio, ranked #78.

Cranbrook Wealth Management first reported a position in TMO in Q2 2018 and has held it in 33 quarters since. The position peaked at $845K in Q4 2025. 2,623 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Cranbrook Wealth Management held 1,368 shares of Thermo Fisher Scientific worth $686K as of Q2 2026.
Cranbrook Wealth Management sold 90 Thermo Fisher Scientific shares in Q2 2026, an estimated $43.2K.
Thermo Fisher Scientific made up 0.13% of Cranbrook Wealth Management's portfolio in Q2 2026, its #78 holding.
Cranbrook Wealth Management first reported a position in Thermo Fisher Scientific in Q2 2018 and has held it in 33 quarters since.
Cranbrook Wealth Management's Thermo Fisher Scientific position peaked at $845K in Q4 2025.
2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Cranbrook Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.